Congress Materials

Medical Information
Gulf Countries
 

This medical information website is intended only for healthcare professionals in the following Gulf Countries (UAE, Oman, Bahrain, Qatar and Kuwait). This information is not intended as medical advice. Responsibility for patient care resides with the healthcare professional on the basis of his or her professional license, experience and knowledge of the patient.

Please choose the category that best describes you.

I am a Healthcare Professional registered to practice in UAE or Oman or Bahrain or Qatar or KuwaitYes, I am a Healthcare Professional registered to practice in UAE or Oman or Bahrain or Qatar or Kuwait
SelectI am a Healthcare Professional registered to practice in UAE or Oman or Bahrain or Qatar or KuwaitYes, I am a Healthcare Professional registered to practice in UAE or Oman or Bahrain or Qatar or Kuwait
I am a patient / caregiverNo, go back to the patient portal
SelectI am a patient / caregiverNo, go back to the patient portal
I am a Healthcare Professional in another country.
The information on this page pertains to select congresses, congress materials, therapeutic and disease areas. It is not intended to serve as a comprehensive overview of all congresses, congress materials, therapeutic and disease areas.
Poster
Benjamin J. Samelson-Jones, Spencer K. Sullivan, John E. J. Rasko, Adam Giermasz, Lindsey A. George, Jonathan M. Ducore, Jerome M. Teitel, Catherine E. McGuinn, Amanda O'Brien; Ian Winburn, Lynne M. Smith, Amit Chhabra, Jeremy Rupon December 14, 2021 ASH 2021 Hemophilia

Follow-up of More Than 5 Years in a Cohort of Participants With Hemophilia B Treated With Fidanacogene Elaparvovec Adeno-Associated Virus Gene Therapy

View Presentation
Oral Presentation
Nathan Visweshwar, Thomas J. Harrington, Andrew D. Leavitt, Barbara A. Konkle, Adam Giermasz, Kimo C. Stine, Jeremy Rupon, Gregory Di Russo, Li-Jung Tseng, Maria de los Angeles Resa, Florence Ganne, Delphine Agathon, Frank Plonski, Didier Rouy, Bettina M. Cockroft, Annie Fang, Steven Arkin December 14, 2021 ASH 2021 Hemophilia

Updated Results of the Alta Study, a Phase 1/2 Study of Giroctocogene Fitelparvovec (PF-07055480/SB-525) Gene Therapy in Adults With Severe Hemophilia A

View Presentation
Oral Presentation
Lisa Young, Leona Markson, José Alvir, Yong Chen, Tom Burke, Ian Winburn February 2, 2022 EAHAD 2022 Hemophilia

Association Between Annual Bleeding Events and Health-Related Quality of Life in Adults With Haemophilia A Prescribed Prophylaxis

View Presentation
Oral Presentation
Sangeeta Raje, Anna Plotka, Isabelle Huyghe, John Teeter February 2, 2022 EAHAD 2022 Hemophilia

Bioequivalence (BE) of Marstacimab Prefilled Pen (PFP) Device and Prefilled Syringe (PFS) Device Following Subcutaneous (SC) Administration in Healthy Adult Males

View Presentation
Oral Presentation
Jeremy Rupon, Brinda K Tammara, Justin Smith, Delphine Agathon, Florence Ganne, Patrick F Fogarty, Frank Plonski February 2, 2022 EAHAD 2022 Hemophilia

Clearance of Giroctocogene Fitelparvovec Vector DNA in Adults With Severe Haemophilia A

View Presentation
Oral Presentation
Nirmalkumar Choraria, Savita Rangarajan, M Joseph John, Shashikant Apte, Pritam Gupta, Seema Pai, Rohit Chand, Shyam Parvatini, GSH Ramakanth, Jeremy Rupon, Hitesh Bhaskarrao Muley, Damien Simoneau February 2, 2022 EAHAD 2022 Hemophilia

Moroctocog Alfa (AF-CC) Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Patients With Moderate or Severe Hemophilia A in India

View Presentation
Oral Presentation
John Teeter, Robert Charnigo, Nandini Cossons, Sangeeta Raje, Eunhee Hwang, Thomas Le Duigou February 2, 2022 EAHAD 2022 Hemophilia

Safety and Efficacy of Marstacimab for Prevention of Bleeding Episodes in Paediatric Patients With Severe Haemophilia A or Moderately Severe to Severe Haemophilia B With or Without Inhibitors

View Presentation
Oral Presentation
Nirmalkumar Choraria, Savita Rangarajan, M Joseph John, Shashikant Apte, Pritam Gupta, Seema Pai, Rohit Chand; Shyam Parvatini, GSH Ramakanth, Jeremy Rupon, Hitesh Bhaskarrao Muley, Damien Simoneau February 2, 2022 EAHAD 2022 Hemophilia

Safety and Efficacy of Nonacog Alfa Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Patients With Moderately Severe or Severe Haemophilia B in India

View Presentation
Poster
DD Pittman, S Rakhe, J McKay, P Gaitonde, J Rupon May 8, 2022 WFH 2022 Hemophilia

Analysis of FIX Activity Following Addition of Exogenous FIX to Plasma From Participants Treated With Fidanacogene Elaparvovec

View Presentation
Poster
LE Markson, L Young, L Ban, Y Chen, PF Fogarty May 8, 2022 WFH 2022 Hemophilia

Healthcare Resource Use, Depression, and Anxiety Among Adult Males With Hemophilia B: Observed Differences for Those With and Without Medically Recorded Bleeding Episodes in the United States

View Presentation